The Centers for Disease Control and Prevention Sept. 5 alerted clinicians to a recent increase in respiratory syncytial virus in the Southeastern U.S., which could signal the beginning of 2023-2024 RSV season nationally. CDC encourages clinicians to prepare to implement prevention options, including the new long-acting monoclonal antibody to protect infants and some young children at higher risk for severe disease and two new vaccines to protect older adults from severe disease. 

Related News Articles

Headline
The National Institutes of Health Sept. 16 announced it has launched a consortium to help reduce preventable stillbirths across the U.S. The NIH said…
Headline
A blog by Julia Resnick, AHA senior director of health outcomes and care transformation, describes a new project with the Commonwealth Fund that will explore…
Blog
Every pregnant woman deserves access to high-quality maternal care — from conception through postpartum. Yet in parts of the country, some of that care is…
Headline
The AHA Aug. 26 responded to a request for information as part of the introduction of the Healthy Moms and Babies Act, bipartisan legislation that seeks to…
Headline
Nearly 57% of mothers did not attend a postpartum follow-up visit three to eight weeks after giving birth, according to a report published July 29 by Cedar…
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…